Welcure Drugs & Pharmaceuticals informs about statement of investor grievances

08 Oct 2024 Evaluate
Welcure Drugs & Pharmaceuticals has informed that the statement of Investor Grievances pursuant to Regulation 13 (3) of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 as provided by its Registrar and Transfer Agent - Skyline Financial Services for the quarter and half year ended 30th September, 2024 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

8.30 0.14 (1.72%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Redington 245.50
Adani Enterprises 2351.30
Amrapali Industries 17.33
Rashi Peripheral 294.25
Prithvi Exchange (I) 167.90
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...